Gao, T., Liu, J., Tan, Z., Bai, C., Shi, Y., Li, S., Zhang, L., Wang, X., Fang, Z., Tan, X., Xi, R., Deng, T., Xue, R., Fan, Z. (2026). Camrelizumab combined with liposomal doxorubicin and dacarbazine as first-line therapy for advanced, recurrent, and metastatic undifferentiated pleomorphic sarcoma: A phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11513